VPIX Medical, a **Medical Devices** startup founded in **2016** in **Korea South**, has been pioneering the development of a real-time digital biopsy platform for cancer surgery. With the slogan "Real-time Digital Biopsy Platform for Cancer Surgery," the company is focused on creating an on-demand tissue imaging fluorescence endomicroscopic system. Leveraging innovative technology from KAIST, VPIX Medical has garnered recognition through its selection as a government-sponsored project and is currently undergoing validation testing. The startup received a **Non Equity Assistance investment** on **01 November 2017**, with funding from the **TIPS Program**. VPIX Medical's commitment to advancing medical technology for cancer surgery positions it as a compelling prospect for venture capital investment. This venture holds promising potential in addressing critical needs within the medical industry, and as a result, it represents an opportunity for impactful investment with significant social and financial returns.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Non Equity Assistance | Unknown | 1 | TIPS Program | 01 Nov 2017 |